Demographic
characteristics
|
|
Male : female |
4 : 10 |
Age (years): median (range) |
23 (4 – 38) |
Comorbidities
|
|
Malaria: n/N (%) patients tested |
11/13 (85%) |
HIV: n/N (%) patients tested |
1/3 (7%) |
General
characteristics
|
|
Time (days) from symptom onset to treatment
start: median (range) |
21 (5–45) |
Signs and symptoms: n/N (%)
patients
|
|
Fever (temperature >38·0
°C) |
9/14 (64%) |
Patients with lesions: |
14/14 (100%) |
Patients with new lesions |
10/14 (71%) |
Number of patients with >100
lesions |
11/14 (79%) |
Outcome: n/N (%)
patients
|
|
Completed full course of treatment |
14/14 (100%) |
PCR positive at day 4 |
7/14 (50%) |
PCR positive at day 8 |
1/10 (10%) |
PCR positive at day 14 |
1/8 (12%) |
PCR positive at day 21 |
1/2 (50%) |
PCR positive at final visit |
1/13 (8%) |
Time (days) to no new lesions: median
(range) |
5 (0–28) |
Recovered without sequelae at D28 |
4/13 (31%) |
Recovered with sequelae at D28 |
9/13 (69%) |
Patients with at least one serious adverse
event |
2/14 (14%) |